Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kocaeli Derince Education and Research Hospital
Atherosclerotic cardiovascular disease is markedly increased in chronic kidney disease. There are a lot of risk factor, along with conventional risk factors. Serum onemtin-1 is a adipokine and suggested as a new marker for vascular disease.It has some anti-atherogenic properties. Studies investigating serum omentin-1 level have usually conducted in patients with diabetes mellitus.
Age
18–75
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
between ages of 18 - 65 years old chronic kidney disease of stage 3-4
You may not be if
Chronic kidney disease of stage 5
The history of ischemic cardiovascular disease (myocardial infarction, unstable angina, stroke, peripheral artery disease, or cardiovascular revascularization)
Severe heart failure
Stage 2 hypertension
Diabetes mellitus
Corticosteroid therapy
Severe hepatic disease
Smoking
Inflammatory disease
Acute infectious disease
Malignancy
Clareo Health | Serum Omentin-1 and Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease
